These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 16373409

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Efficacy and tolerability of vaginal progesterone capsules (Utrogest 200) compared with progesterone gel (Crinone 8%) for luteal phase support during assisted reproduction.
    Kleinstein J, Luteal Phase Study Group.
    Fertil Steril; 2005 Jun; 83(6):1641-9. PubMed ID: 15950631
    [Abstract] [Full Text] [Related]

  • 25. Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists.
    Kolibianakis EM, Papanikolaou EG, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.
    Hum Reprod; 2006 Apr; 21(4):1012-7. PubMed ID: 16339166
    [Abstract] [Full Text] [Related]

  • 26. GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study.
    Ata B, Yakin K, Balaban B, Urman B.
    Hum Reprod; 2008 Mar; 23(3):668-73. PubMed ID: 18192671
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
    Weitzman VN, Engmann L, DiLuigi A, Maier D, Nulsen J, Benadiva C.
    Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
    [Abstract] [Full Text] [Related]

  • 30. GnRHa to trigger final oocyte maturation: a time to reconsider.
    Humaidan P, Papanikolaou EG, Tarlatzis BC.
    Hum Reprod; 2009 Oct; 24(10):2389-94. PubMed ID: 19608565
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P, Kovats T, Bernard A, Zadori J, Szmatona G, Kaali SG.
    Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Serum estradiol the day of hCG administration as predictor factor of IVF-ET].
    Kably Ambe A, Estévez González S, Carballo Mondragón E.
    Ginecol Obstet Mex; 2008 Apr; 76(4):197-201. PubMed ID: 18798418
    [Abstract] [Full Text] [Related]

  • 38. Progesterone elevation on the day of human chorionic gonadotropin administration adversely affects the outcome of IVF with transferred embryos at different developmental stages.
    Huang Y, Wang EY, Du QY, Xiong YJ, Guo XY, Yu YP, Sun YP.
    Reprod Biol Endocrinol; 2015 Aug 04; 13():82. PubMed ID: 26238449
    [Abstract] [Full Text] [Related]

  • 39. Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles.
    Simberg N, Tulppala M, Husa LM, Tiitinen A.
    Acta Obstet Gynecol Scand; 1998 Sep 04; 77(8):854-9. PubMed ID: 9776601
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.